Position in PGEN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$321,643
-$96,912 QoQ
Shares Held
83,112
-17.0% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $374,315,342 across 207 Biotechnology names. PGEN ranks #127 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
70,804 | $31,616,818 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
80,930 | $26,074,836 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
152,645 | $25,800,057 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
374,931 | $24,231,790 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
23,567 | $18,208,806 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
1,805,184 | $17,004,833 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,738,062 | $15,659,938 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
|
708,527 | $13,858,788 |
All Filings in PGEN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $321,643 | 83,112 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $418,555 | 100,133 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $277,402 | 84,317 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $118,459 | 83,422 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $123,939 | 83,181 | Shares | Defined | 2025-05-14 | |
| 2024-09-30 | $2,499 | 2,631 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $116,209 | 73,550 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $98,120 | 67,669 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $88,659 | 66,164 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $93,952 | 66,164 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $76,088 | 66,164 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $70,133 | 66,164 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $26,548 | 17,466 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $115,020 | 54,255 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $49,328 | 13,296 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $172,459 | 34,561 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $75,273 | 11,545 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $199,541 | 28,961 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $189,434 | 18,572 | Shares | Defined | 2023-03-23 | |
| 2020-09-30 | $51,590 | 14,740 | Shares | Defined | 2023-03-23 | |
| 2020-06-30 | $163,502 | 32,766 | Shares | Defined | 2023-03-23 | |
| 2020-03-31 | $111,404 | 32,766 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||